Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 157 publications
Atogepant for the preventive treatment of episodic migraine in Japanese participants: A phase 2/3, randomized, double-blind, placebo-controlled trial with an active treatment extension (RELEASE).
Journal: Cephalalgia : an international journal of headache
Published: September 26, 2025
Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence.
Journal: Cephalalgia : an international journal of headache
Published: August 28, 2025
Long-term safety, efficacy and functional outcomes of atogepant for the preventive treatment of migraine.
Journal: Cephalalgia : an international journal of headache
Published: August 20, 2025
Can atogepant be a preventive treatment for cluster headache?-Insights from a case series.
Journal: Headache
Published: June 29, 2025
Oral atogepant mitigates spreading depolarization-induced pain and anxiety behavior in mice.
Journal: The journal of headache and pain
Published: June 24, 2025
Small-molecule CGRP antagonist atogepant does not affect cortical spreading depression susceptibility in rats.
Journal: The journal of headache and pain
Published: June 19, 2025
One-month atogepant treatment induces rapid changes in delta-band functional connectivity in migraine: an HD-EEG study.
Journal: The journal of headache and pain
Published: June 18, 2025
The role of Atogepant in migraine prevention: a systematic review and meta-analysis.
Journal: BMC neurology
Published: June 18, 2025
Pharmacological characterization of ubrogepant and atogepant in cAMP assays at human, rat, and mouse calcitonin family receptors in transfected cells.
Journal: Biochemical pharmacology
Published: June 13, 2025
Retrospective cohort study of anti-CGRP monoclonal antibody unresponsive migraine individuals treated with atogepant: The RESCUE study.
Journal: Cephalalgia : an international journal of headache
Published: June 12, 2025
Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system.
Journal: PloS one
Published: June 09, 2025
"The efficacy and safety of Atogepant for migraine prophylaxis: a systematic review and meta-analysis of randomized controlled trials".
Journal: BMC neurology
Published: May 31, 2025
Last Updated: 10/31/2025